BioTime to Participate in Upcoming Conferences

On November 13, 2017 BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, reported that its management will participate in the following conferences (Press release, BioTime, NOV 13, 2017, View Source;p=RssLanding&cat=news&id=2316395 [SID1234521958]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Torrey Hills Capital Emerging Growth Conference on Tuesday, November 14, 2017. This conference is being held at the Morgan Run Club and Resort in Rancho Santa Fe, CA.
LD Micro 10th Annual Main Event Conference on Wednesday, December 6, 2017. This conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
At each conference mentioned above the Company will be hosting one-on-one and group meetings throughout the day. Analysts and portfolio managers that wish to attend the conference or would like to request a meeting should contact Torrey Hills Capital or LD Micro.